$SKIN
Beauty Health Co Stock $skin

$skin Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000162828023028569 Filed on August 09, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q2
Revenue	$97.41M	$117.5M	$103.5M
YoY Change	9.71%	13.47%	55.67%
Cost Of Revenue	$110.0M	$49.60M	$31.88M
YoY Change	304.03%	55.58%	65.56%
Gross Profit	-$12.55M	$67.88M	$71.65M
YoY Change	-120.39%	-5.27%	51.65%
Gross Profit Margin	-12.89%	57.78%	69.21%
Selling, General & Admin	$67.71M	$78.14M	$69.79M
YoY Change	6.55%	11.97%	-1.17%
% of Gross Profit		115.12%	97.4%
Research & Development	$1.839M	$2.881M	$2.601M
YoY Change	-15.14%	10.77%	-12.95%
% of Gross Profit		4.24%	3.63%
Depreciation & Amortization	$7.350M	$9.901M	$4.590M
YoY Change	267.32%	115.71%	555.71%
% of Gross Profit		14.59%	6.41%
Operating Expenses	$69.55M	$81.02M	$75.07M
YoY Change	5.83%	7.93%	1.99%
Operating Profit	-$82.10M	-$13.15M	-$3.413M
YoY Change	1882.64%	285.17%	-87.05%
Interest Expense	$3.445M	$2.685M	-$5.423M
YoY Change	-201.92%	-149.51%	163.25%
% of Operating Profit
Other Income/Expense, Net	$4.872M	$11.63M	$16.84M
YoY Change	41.18%	-30.94%	-114.66%
Pretax Income	-$70.34M	$1.171M	$8.007M
YoY Change	10094.06%	-85.38%	-105.67%
Income Tax	$3.500M	-$2.193M	$76.00K
% Of Pretax Income		-187.28%	0.95%
Net Earnings	-$73.82M	$3.364M	$7.931M
YoY Change	-56449.62%	-57.58%	-105.69%
Net Earnings / Revenue	-75.78%	2.86%	7.66%
Basic Earnings Per Share	-$0.56	$0.03	$0.04
Diluted Earnings Per Share	-$0.56	$0.03	$52.27K
COMMON SHARES
Basic Shares Outstanding	132.9M shares	132.7M shares	150.6M shares
Diluted Shares Outstanding	132.9M shares	132.7M shares	151.7M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$559.4M	$549.7M	$821.0M
YoY Change	-18.24%	-33.04%	709.1%
Cash & Equivalents	$559.4M	$549.7M	$821.0M
Short-Term Investments
Other Short-Term Assets	$35.90M	$30.94M	$20.34M
YoY Change	64.45%	52.14%	323.31%
Inventory	$74.88M	$107.0M	$73.53M
Prepaid Expenses
Receivables	$66.81M	$74.63M	$79.92M
Other Receivables	$1.000M	$5.642M	$1.008M
Total Short-Term Assets	$738.0M	$767.9M	$995.8M
YoY Change	-17.3%	-22.88%	470.83%
LONG-TERM ASSETS
Property, Plant & Equipment	$29.40M	$31.75M	$33.83M
YoY Change	-9.23%	-6.16%	234.54%
Goodwill	$124.7M	$125.4M
YoY Change	1.57%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$15.54M	$16.86M	$10.14M
YoY Change	50.41%	66.39%	307.19%
Total Long-Term Assets	$235.1M	$239.5M	$219.2M
YoY Change	10.69%	9.27%	30.42%
TOTAL ASSETS
Total Short-Term Assets	$738.0M	$767.9M	$995.8M
Total Long-Term Assets	$235.1M	$239.5M	$219.2M
Total Assets	$973.1M	$1.007B	$1.215B
YoY Change	-11.92%	-17.08%	254.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$35.88M	$29.38M	$36.83M
YoY Change	10.15%	-20.23%	112.55%
Accrued Expenses	$30.49M	$50.20M	$47.72M
YoY Change	78.2%	5.2%	122.98%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$125.9M	$82.79M	$87.06M
YoY Change	64.68%	-4.9%	120.44%
LONG-TERM LIABILITIES
Long-Term Debt	$737.3M	$736.3M	$732.0M
YoY Change	0.57%	0.58%
Other Long-Term Liabilities	$410.0K	$24.57M	$39.70M
YoY Change	-98.78%	-38.1%	2146.46%
Total Long-Term Liabilities	$410.0K	$760.8M	$771.7M
YoY Change	-99.95%	-1.41%	43574.19%
TOTAL LIABILITIES
Total Short-Term Liabilities	$125.9M	$82.79M	$87.06M
Total Long-Term Liabilities	$410.0K	$760.8M	$771.7M
Total Liabilities	$883.1M	$845.6M	$862.6M
YoY Change	4.28%	-1.97%	164.25%
SHAREHOLDERS EQUITY
Retained Earnings	-$469.5M	-$395.6M
YoY Change	24.15%
Common Stock	$14.00K	$14.00K
YoY Change	-6.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$89.96M	$161.8M	$352.3M
YoY Change
Total Liabilities & Shareholders Equity	$973.1M	$1.007B	$1.215B
YoY Change	-11.92%	-17.08%	254.72%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q2
OPERATING ACTIVITIES
Net Income	-$73.82M	$3.364M	$7.931M
YoY Change	-56449.62%	-57.58%	-105.69%
Depreciation, Depletion And Amortization	$7.350M	$9.901M	$4.590M
YoY Change	267.32%	115.71%	555.71%
Cash From Operating Activities	$17.96M	$21.97M	-$31.34M
YoY Change	-157.2%	-170.1%	-0.29%
INVESTING ACTIVITIES
Capital Expenditures	$2.890M	$3.219M	-$3.404M
YoY Change	-137.33%	-194.57%	-31.65%
Acquisitions
YoY Change
Other Investing Activities	-$1.540M	$0.00	-$1.475M
YoY Change		-100.0%	-64.36%
Cash From Investing Activities	-$4.440M	-$3.219M	-$4.879M
YoY Change	-42.64%	-34.02%	-46.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-2.350M	-1.546M	-1.980M
YoY Change	-97.65%	-21.92%	-101.49%
NET CHANGE
Cash From Operating Activities	17.96M	21.97M	-31.34M
Cash From Investing Activities	-4.440M	-3.219M	-4.879M
Cash From Financing Activities	-2.350M	-1.546M	-1.980M
Net Change In Cash	11.17M	17.20M	-38.19M
YoY Change	-108.03%	-145.04%	-141.29%
FREE CASH FLOW
Cash From Operating Activities	$17.96M	$21.97M	-$31.34M
Capital Expenditures	$2.890M	$3.219M	-$3.404M
Free Cash Flow	$15.07M	$18.75M	-$27.93M
YoY Change	-163.69%	-167.12%	5.61%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	19145000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	15183000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	82789000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	71714000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	10628000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	12689000	usd
CY2023Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	2015000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	2011000	usd
CY2023Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	12964000	usd
CY2022Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	15473000	usd
CY2023Q2	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	736257000	usd
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	734143000	usd
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	979000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	0	usd
CY2023Q2	us-gaap	Liabilities Liabilities	845632000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	836030000	usd
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	320000000	shares
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	320000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	132881417	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	132881417	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	14000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	14000	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	561483000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	550320000	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4009000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4530000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-395646000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-378751000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	161842000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	167053000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1007474000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1003083000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	117479000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	103536000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	67876000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	70040000	usd
CY2023Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	43041000	usd
CY2022Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	44881000	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2881000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2601000	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	35100000	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	27585000	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	81022000	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	75067000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-13146000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-5027000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	3429000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	3217000	usd
CY2023Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	5717000	usd
CY2022Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	743000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	47000	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	915000	usd
CY2023Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-11585000	usd
CY2023Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	397000	usd
CY2022Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-2206000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1171000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	6393000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2193000	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2630000	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	132716024	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	150731491	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	132716024	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	151719451	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	298034000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7049000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-145000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	336393000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	6317000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	500000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6378000	usd
CY2022Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	495000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-3687000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	345406000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	167053000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-20259000	usd
CY2023Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	2195000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	2034000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	1310000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	888000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	152408000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	3364000	usd
CY2023Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	545000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	698000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8524000	usd
CY2023Q2	us-gaap	Accelerated Share Repurchase Program Adjustment AcceleratedShareRepurchaseProgramAdjustment	-2240000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-367000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	161842000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-16895000	usd
	us-gaap	Net Income Loss NetIncomeLoss	37772000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	12101000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	13427000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	11126000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7371000	usd
	us-gaap	Depreciation Depreciation	4483000	usd
	us-gaap	Depreciation Depreciation	3268000	usd
	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	1107000	usd
	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	280000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2114000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2114000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	4365000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	2028000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1380000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	435000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2509000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-67237000	usd
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	1796000	usd
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	5108000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	138000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	34410000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2605000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	38596000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	12188000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5209000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	9239000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	8449000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	4420000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	4606000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	8956000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-69806000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	4365000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1252000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3623000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5577000	usd
	skin	Payments For Asset Acquisitions PaymentsForAssetAcquisitions	16915000	usd
	skin	Payments For Asset Acquisitions PaymentsForAssetAcquisitions	1475000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-24903000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8304000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2083000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	usd
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	2763000	usd
	skin	Payment Of Accelerated Share Repurchases PaymentOfAcceleratedShareRepurchases	2240000	usd
	skin	Payment Of Accelerated Share Repurchases PaymentOfAcceleratedShareRepurchases	0	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	582000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3741000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2763000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-19688000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-80873000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1219000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-43000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	568197000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	901886000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	549728000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	820970000	usd
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	117479000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	103536000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	203757000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	178951000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	117479000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	103536000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	203757000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	178951000	usd
CY2023Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	32267000	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	38373000	usd
CY2023Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	74733000	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	71283000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	107000000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	109656000	usd
CY2023Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	10149000	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	4154000	usd
CY2023Q2	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	2014000	usd
CY2022Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	1357000	usd
CY2023Q2	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	5089000	usd
CY2022Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	5643000	usd
CY2023Q2	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	8902000	usd
CY2022Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	10523000	usd
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	26154000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	21677000	usd
CY2023Q2	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	7271000	usd
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	4904000	usd
CY2023Q2	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	4045000	usd
CY2022Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	2348000	usd
CY2023Q2	us-gaap	Interest Payable Current InterestPayableCurrent	2344000	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	2344000	usd
CY2023Q2	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	0	usd
CY2022Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	1819000	usd
CY2023Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	5485000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3768000	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	19145000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	15183000	usd
CY2023Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	16862000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	12494000	usd
CY2023Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	17958000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	18184000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	145309000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	79740000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	65569000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	114806000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	68420000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	46386000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	124593000	usd
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	758000	usd
CY2023Q2	us-gaap	Goodwill Goodwill	125351000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-5900000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2700000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2200000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	100000	usd
CY2023Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-1.873
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.257
CY2022Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.012
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.067
CY2023Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1000000	usd
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	200000	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8524000	usd
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6378000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12101000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	13427000	usd
CY2023Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	79100000	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y2M12D
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	320000000	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	skin	Common Stock Voting Rights Votes CommonStockVotingRightsVotes	1	vote
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	132881417	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	132881417	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	132214695	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	132214695	shares
CY2022Q3	skin	Number Of Stock Repurchase Programs NumberOfStockRepurchasePrograms	2	program
CY2022Q4	skin	Number Of Stock Repurchase Programs NumberOfStockRepurchasePrograms	2	program
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3364000	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	6317000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-16895000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	37772000	usd
CY2023Q2	skin	Warrant Down Round Feature Decrease In Net Income To Common Shareholder Amount WarrantDownRoundFeatureDecreaseInNetIncomeToCommonShareholderAmount	0	usd
CY2022Q2	skin	Warrant Down Round Feature Decrease In Net Income To Common Shareholder Amount WarrantDownRoundFeatureDecreaseInNetIncomeToCommonShareholderAmount	15185000	usd
	skin	Warrant Down Round Feature Decrease In Net Income To Common Shareholder Amount WarrantDownRoundFeatureDecreaseInNetIncomeToCommonShareholderAmount	0	usd
	skin	Warrant Down Round Feature Decrease In Net Income To Common Shareholder Amount WarrantDownRoundFeatureDecreaseInNetIncomeToCommonShareholderAmount	67237000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	3364000	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-8868000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-16895000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-29465000	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	132716024	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	150731491	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	132569209	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	150665166	shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2022Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	987960	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	1609228	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	132716024	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	151719451	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	132569209	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	152274394	shares
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.25
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.19
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	298000000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	152400000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	109656000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	27648000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	783275000	usd
CY2022Q4	us-gaap	Assets Assets	1003083000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	28467000	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	1429000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	71714000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	836030000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-378751000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	167053000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1003083000	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	33496000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	70040000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-5027000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	6393000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	6317000	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2630000	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
	us-gaap	Cost Of Revenue CostOfRevenue	58026000	usd
	us-gaap	Gross Profit GrossProfit	120925000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-19040000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	40463000	usd
	us-gaap	Net Income Loss NetIncomeLoss	37772000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	33940000	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.25
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.19
	us-gaap	Net Income Loss NetIncomeLoss	37772000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	38596000	usd

Files In Submission

Name	View Source	Status
0001628280-23-028569-index-headers.html	Edgar Link	pending
0001628280-23-028569-index.html	Edgar Link	pending
0001628280-23-028569.txt	Edgar Link	pending
0001628280-23-028569-xbrl.zip	Edgar Link	pending
ex311-2023q210xq.htm	Edgar Link	pending
ex312-2023q210xq.htm	Edgar Link	pending
ex321-2023q210xq.htm	Edgar Link	pending
ex322-2023q210xq.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
skin-20230630.htm	Edgar Link	pending
skin-20230630.xsd	Edgar Link	pending
skin-20230630_def.xml	Edgar Link	unprocessable
skin-20230630_lab.xml	Edgar Link	unprocessable
skin-20230630_pre.xml	Edgar Link	unprocessable
skin-20230630_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
skin-20230630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SKIN
Beauty Health Co Stock $skin

2023 Q3 Form 10-Q Financial Statement

#000162828023028569 Filed on August 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SKIN Beauty Health Co Stock $skin

2023 Q3 Form 10-Q Financial Statement

#000162828023028569 Filed on August 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SKIN
Beauty Health Co Stock $skin